NewsTurkish Diabetes Foundation - ''PERSPECTIVES ON DIABETES'' – ONLINE CONVERSATION SERIES BY THE TURKISH DIABETES FOUNDATION | Turkish Diabetes Foundation
![PDF) Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey – GALATA study | Mehmet Akif Buyukbese - Academia.edu PDF) Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey – GALATA study | Mehmet Akif Buyukbese - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/37180685/mini_magick20190304-7696-svx0qm.png?1551748191)
PDF) Real-life safety and efficacy of vildagliptin as add-on to metformin in patients with type 2 diabetes in Turkey – GALATA study | Mehmet Akif Buyukbese - Academia.edu
![KS -Klinik Seriler - TIP DERGİSİ Haziran 1992 Cilt 3 Sayı 2 Sempozyum DİABETES MELLİTUS - KOLEKTİF | Nadir Kitap KS -Klinik Seriler - TIP DERGİSİ Haziran 1992 Cilt 3 Sayı 2 Sempozyum DİABETES MELLİTUS - KOLEKTİF | Nadir Kitap](https://static.nadirkitap.com/fotograf/121065/27/Kitap_2022040621304312106512.jpg)
KS -Klinik Seriler - TIP DERGİSİ Haziran 1992 Cilt 3 Sayı 2 Sempozyum DİABETES MELLİTUS - KOLEKTİF | Nadir Kitap
![HaberlerTürkiye Diyabet Vakfı - ''PERSPECTIVES ON DIABETES'' – ONLINE CONVERSATION SERIES BY THE TURKISH DIABETES FOUNDATION | Türkiye Diyabet Vakfı HaberlerTürkiye Diyabet Vakfı - ''PERSPECTIVES ON DIABETES'' – ONLINE CONVERSATION SERIES BY THE TURKISH DIABETES FOUNDATION | Türkiye Diyabet Vakfı](https://www.turkdiab.org/admin/PICS/images/haberler/tdvvv.jpg)
HaberlerTürkiye Diyabet Vakfı - ''PERSPECTIVES ON DIABETES'' – ONLINE CONVERSATION SERIES BY THE TURKISH DIABETES FOUNDATION | Türkiye Diyabet Vakfı
Türk Böbrek Vakfı - Turkish Kidney Foundation on X: "🔵14 Kasım Dünya Diyabet Günü 20-79 yaş aralığındaki dünya nüfusunun 425 milyonunun diyabetli olduğunu, 2045'te bu sayının 629 milyon olmasının beklendiğini biliyor musunuz?
![Professor Gokhan Hotamisligil Receives 2018 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence Professor Gokhan Hotamisligil Receives 2018 EASD–Novo Nordisk Foundation Diabetes Prize for Excellence](http://www.tc-america.org/images/news/2018/gokhan-s-hotamsisligil.jpg)